Dr. Eduardo Anitua, representing the Basque bio-tech company BTI Biotechnology Institute, gave a paper at the international conference in May of the prestigious American organisation, the Hopkins Biotech Network (part of the Johns Hopkins University), at its Montgomery County Campus in Rockville (Indiana, U.S.A.).

Dr. Anitua took advantage of his appearance at this forum to present the latest advances made by BTI Biotechnology Institute in the field of regenerative therapy, one of the key areas of the intense research work carried out by this company from Alava, which has resulted in the development of a technique called Plasma Rich in Growth Factors (PRGF). This is a bio-tech product consisting of a concentration of proteins collected from patients themselves, which is then used to stimulate the regeneration of tissues for bones, muscles, tendons, skin or corneas.

This technology, pioneered in the world by BTI, means that it is possible to regenerate old or damaged tissue without the need for invasive surgery. It has opened up new horizons in the field of Regenerative Therapy, and has multiple applications in oral surgery, maxillofacial surgery, implantology, traumatology, dermatology, plastic surgery, sports medicine, ophthalmology and general surgery.

Another of Dr Anitua’s main themes at the conference in the Hopkins Biotech Network was the use of growth factors in stem cell therapies that make use of a biological matrix for the transplant of stem cells known as a scaffold. These subjects were later discussed during sessions with the Department of Regenerative Therapy of the Johns Hopkins University, one of the most prestigious centres in this field at international level.